AiMorphous Health
AiMorphous Health is a Swiss Medtech startup pioneering AI-powered blood diagnostics to predict thrombosis and bleeding risks. Their innovative blood test identifies early biomarkers of thrombosis using advanced machine learning algorithms to analyze blood samples with high accuracy. This early detection technology aims to prevent life-threatening cardiovascular events such as heart attacks, strokes, and emboli, potentially saving many lives and reducing healthcare burdens. The company is recognized for its breakthrough approach in thrombosis prevention and management, supported by accelerator programs and financial backing, positioning it as a promising player in the medtech and AI diagnostics market.
AiMorphous Health
AiMorphous Health is a Swiss Medtech startup pioneering AI-powered blood diagnostics to predict thrombosis and bleeding risks. Their innovative blood test identifies early biomarkers of thrombosis using advanced machine learning algorithms to analyze blood samples with high accuracy. This early detection technology aims to prevent life-threatening cardiovascular events such as heart attacks, strokes, and emboli, potentially saving many lives and reducing healthcare burdens. The company is recognized for its breakthrough approach in thrombosis prevention and management, supported by accelerator programs and financial backing, positioning it as a promising player in the medtech and AI diagnostics market.